➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
AstraZeneca
Johnson and Johnson
Dow
McKinsey

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Sentius International, LLC v. Apple Inc. (N.D. Cal. 2020)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Sentius International, LLC v. Apple Inc. (N.D. Cal. 2020)

Docket   Start Trial Date Filed 2020-01-22
Court District Court, N.D. California Date Terminated
Cause 35:271 Patent Infringement Assigned To Yvonne Gonzalez Rogers
Jury Demand Plaintiff Referred To
Parties APPLE, INC.; SENTIUS INTERNATIONAL, LLC
Patents 10,014,079; 10,035,838; 10,036,037; 10,173,985; 10,496,838; 10,550,193; 10,550,437; 10,556,008; 10,556,024; 10,556,037; 10,556,942; 6,146,672; 7,018,985; 7,045,601; 7,078,020; 7,232,919; 7,244,877; 7,316,067; 7,488,316; 7,488,496; 7,705,045; 7,713,570; 7,713,929; 7,838,227; 8,006,690; 8,062,044; 8,193,182; 8,343,985; 8,633,178; 8,699,019; 8,822,496; 8,822,651; 8,877,193; 8,877,480; 8,877,705; 8,883,244; 8,883,794; 8,883,838; 9,005,182; 9,011,957; 9,012,437; 9,023,646; 9,062,101; 9,173,942; 9,193,797; 9,522,945; 9,651,550; 9,651,556; 9,656,991; 9,763,945; 9,763,985; 9,797,901; 9,797,953; 9,815,945; 9,822,129; 9,868,838; RE43,797
Attorneys Alton L. Absher; Alton Luther Absher , III; Andrew Nathan Saul; Bindu Ann George Palapura; Brian E. Farnan; David Ellis Moore; Mansi Hasendra Shah; Matthew Joseph Meyer; Michael J. Farnan; Robert J Yorio , Jr.; Robert Joseph Yorio; Sandeep Seth; Steven David Moore; Tracey E. Timlin
Firms Carr and Ferrell LLP; Farnan LLP; Kilpatrick Townsend & Stockton LLP; Kilpatrick Townsend and Stockton LLP; Stubbs Alderton and Markiles LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Sentius International, LLC v. Apple Inc.

Details for Sentius International, LLC v. Apple Inc. (N.D. Cal. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-04-09 41 Dismiss .S. Patent No. RE43,633 and of joint infringement of U.S. Patent Nos. 8 RE43,633 and 7,672,985. This….S. Patent No. RE43,633 and of joint infringement of U.S. Patent Nos. RE43,633 and 15 7,672,985 under… all asserted claims of the ʼ633 patent and U.S. Patent No. 7,672,985. 23 First, Sentius alleges…joint infringement of U.S. Patent Nos. RE43,633 and 15 7,672,985 should be dismissed for…accused of infringing the ‘633 and ‘985 Patents ([“]Accused Apple Products”) provide a specific External link to document
2020-04-27 48 Opposition/Response to Motion claim for direct infringement of the ‘633 10 and ‘985 Patents on a joint or divided infringement theory…infringement of method claims in the ‘633 and ‘985 10 Patents. For all the reasons set forth above, these… method Claim 62 of the ‘633 Patent and method Claim 1 of the ‘985 Patent. As noted by the Court 28 …required by the method claims of the ‘633 Patent and the ‘985 Patent are all automatically 17 performed…grammar suggestions. See SAC ¶¶ 50 (‘633 Patent) and 70 (‘985 Patent) (“Apple’s 24 design of such software External link to document
2020-06-02 55 Order on Motion to Dismiss infringement of two of its patents, namely U.S. 14 Patent No. RE43,633 (the…Complaint for Patent Infringment. Amended Pleadings due by 6/23/2020. Responses due by 7/14/2020. (fs,… 10 activity or receipt of a benefit upon performance of a step or steps of a patented method”…the “’633 Patent”) and 7,672,985 (the “’985 Patent”). Now before the …633 Patent, as well as claims 1 and 11 of the 24 ’985 Patent, through External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Mallinckrodt
McKesson
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.